Compare CRGO & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRGO | CATX |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.4M | 211.1M |
| IPO Year | N/A | N/A |
| Metric | CRGO | CATX |
|---|---|---|
| Price | $2.73 | $2.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $11.56 |
| AVG Volume (30 Days) | 120.7K | ★ 1.2M |
| Earning Date | 02-23-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $28,642,000.00 | $1,075,000.00 |
| Revenue This Year | $26.59 | N/A |
| Revenue Next Year | $23.43 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.55 | N/A |
| 52 Week Low | $1.72 | $1.60 |
| 52 Week High | $4.42 | $5.39 |
| Indicator | CRGO | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 57.52 | 39.93 |
| Support Level | $2.00 | $2.33 |
| Resistance Level | $2.44 | $2.66 |
| Average True Range (ATR) | 0.19 | 0.20 |
| MACD | 0.07 | -0.05 |
| Stochastic Oscillator | 88.89 | 0.80 |
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.